GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GTBP | AZN | AMGN | GILD | BMY |
| Company | GT Biopharma Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.3640 | 198.85 | 350.23 | 136.18 | 59.15 |
| High | 0.3892 | 198.99 | 350.23 | 136.34 | 59.22 |
| Low | 0.3618 | 195.85 | 340.06 | 132.22 | 57.79 |
| Latest | 0.3793 | 197.01 | 345.58 | 132.87 | 59.22 |
| Change | +0.0080 | -3.68 | -4.58 | -3.00 | +0.09 |
| % Change | +2.15% | -1.83% | -1.31% | -2.21% | +0.15% |
| Volume | 246,020 | 967,422 | 674,854 | 1,837,625 | 2,751,658 |
| 20-Day Average Volume | 525,735 | 1,801,590 | 2,374,148 | 5,026,351 | 9,522,496 |
| Previous Close | 0.3713 | 200.69 | 350.16 | 135.87 | 59.13 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.4096 | 198.36 | 349.66 | 138.43 | 59.07 |
| 20-Day Raw Stochastic | 18.85% | 56.04% | 36.83% | 3.44% | 42.08% |
| 20-Day Relative Strength | 39.90 | 48.99 | 43.60 | 38.19 | 49.77 |
| Weighted Alpha | -86.15 | +38.92 | +20.87 | +24.25 | +26.57 |
| Today's Opinion | 100% Sell | 72% Buy | 24% Buy | 24% Buy | 48% Buy |
| Previous Opinion | 100% Sell | 88% Buy | 56% Buy | 40% Buy | 64% Buy |
| Last Month's Opinion | 88% Sell | 40% Buy | 56% Buy | 56% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.88% since 04/14/26 | -3.93% since 04/14/26 | -1.97% since 04/14/26 | -5.60% since 04/14/26 | +1.38% since 04/14/26 |
| Low | 0.3638 on 04/20/26 | 195.85 on 04/21/26 | 340.40 on 04/21/26 | 132.22 on 04/21/26 | 57.22 on 04/15/26 |
| High | 0.4000 on 04/16/26 | 205.30 on 04/17/26 | 356.90 on 04/20/26 | 140.96 on 04/15/26 | 60.48 on 04/17/26 |
| 1-Month | |||||
| %Chg | -17.89% since 03/20/26 | +6.94% since 03/20/26 | -1.08% since 03/20/26 | -3.37% since 03/20/26 | +2.44% since 03/20/26 |
| Low | 0.3506 on 04/13/26 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 132.22 on 04/21/26 | 56.45 on 03/24/26 |
| High | 0.4949 on 03/24/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | -46.79% since 01/21/26 | +8.43% since 01/21/26 | +0.13% since 01/21/26 | +2.70% since 01/21/26 | +8.04% since 01/21/26 |
| Low | 0.3506 on 04/13/26 | 180.34 on 01/22/26 | 335.06 on 04/07/26 | 129.00 on 01/22/26 | 54.21 on 01/29/26 |
| High | 0.7400 on 01/27/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -45.97% since 10/21/25 | +17.97% since 10/21/25 | +14.25% since 10/21/25 | +6.86% since 10/21/25 | +32.20% since 10/21/25 |
| Low | 0.3506 on 04/13/26 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 1.1500 on 11/14/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,716 | 311,251,712 | 188,976,096 | 168,644,832 | 120,727,792 |
| Shares Outstanding, K | 31,554 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -28,350,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -23,030,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 1.19 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.02 on 03/02/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/21/26 | 04/29/26 | 04/30/26 | 05/07/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.36 | 16.26 | 16.89 | 9.78 |